首页> 外文学位 >Selective disruption of hte blood-brain barrier by photochemical internalization.
【24h】

Selective disruption of hte blood-brain barrier by photochemical internalization.

机译:通过光化学内在化选择性破坏血脑屏障。

获取原文
获取原文并翻译 | 示例

摘要

Failure to eradicate infiltrating glioma cells using conventional treatment regimens results in tumor recurrence and is responsible for the dismal prognosis of patients with glioblastoma multiforme (GBM). This is due to the fact that migrating glioma cells are protected by the blood-brain barrier (BBB) which prevents the delivery of most anti-cancer agents. The overall objective of this work was to evaluate the ability of photochemical internalization (PCI) to selectively disrupt the BBB in rats. This will permit access of anti-cancer drugs to effectively target infiltrating tumor cells, and potentially improve the treatment effectiveness for malignant gliomas.;PCI treatment, coupling the macromolecule Clostridium perfringens (Cl p) epsilon prototoxin with AlPcS2a-photodynamic therapy (PDT), was performed on non-tumor bearing inbred Fischer rats. T2-weighted and T1-weighted post-contrast magnetic resonance imaging (MRI) scans were used to evaluate the extent of BBB disruption which was inferred from treatment-induced edema and contrast volumes.;The PCI effect in rat brain was found to be dependent on light fluence, photosensitizer concentration, Cl p prototoxin concentration and administration route. Selective disruption of the BBB by PCI was observed for intraperitoneal administration of 1:100 stock dilutions of Cl p prototoxin and photosensitizer concentrations and light fluences of 1 mg/kg and 1 J respectively. Single modality treatments consisting of PDT or Cl p resulted in only minimal damage to the BBB.;PCI was found to be highly effective for inducing selective and localized disruption of the BBB. The extent of BBB opening peaked on day 3 and was completed restored by day 18 after PCI.
机译:使用常规治疗方案未能根除浸润的神经胶质瘤细胞会导致肿瘤复发,并导致多形性胶质母细胞瘤(GBM)患者的预后不良。这是由于以下事实:迁移的神经胶质瘤细胞受到血脑屏障(BBB)的保护,而血脑屏障可阻止大多数抗癌药的递送。这项工作的总体目标是评估光化学内在化(PCI)选择性破坏大鼠血脑屏障的能力。这将允许获得抗癌药物以有效地靶向浸润的肿瘤细胞,并潜在地改善恶性神经胶质瘤的治疗效果。PCI治疗,将大分子产气荚膜梭状芽胞杆菌(Cl p)ε毒素与AlPcS2a-光动力疗法(PDT)结合,在非肿瘤近交Fischer大鼠上进行。 T2加权和T1加权造影后磁共振成像(MRI)扫描用于评估由治疗引起的水肿和造影剂体积推断出的BBB破坏程度。对光通量,光敏剂浓度,Cl p原毒素浓度和给药途径的影响。对于腹膜内施用的Cl p原毒素和光敏剂浓度为1:100的股票稀释液和光通量分别为1 mg / kg和1 J,观察到了PCI对BBB的选择性破坏。由PDT或Cl p组成的单模治疗仅对BBB造成最小的损害。PCI被发现对诱导BBB的选择性和局部破坏非常有效。 BBB开放的程度在第3天达到峰值,并在PCI后第18天完全恢复。

著录项

  • 作者

    Zhang, Michelle Jie.;

  • 作者单位

    University of Nevada, Las Vegas.;

  • 授予单位 University of Nevada, Las Vegas.;
  • 学科 Biophysics Medical.;Health Sciences Oncology.
  • 学位 M.S.
  • 年度 2008
  • 页码 75 p.
  • 总页数 75
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号